Investigation of anticancer properties of caffeinated complexes via computational chemistry methods
Authors:
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 193, 147-155
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Design and synthesis of some novel quinoline derivatives as anticancer and radiosensitizing agents targeting VEGFR tyrosine kinaseJournal of Heterocyclic Chemistry, 2011
- Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligandJournal of Organometallic Chemistry, 2010
- Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsionsColloids and Surfaces B: Biointerfaces, 2010
- Amide Linkage Isomerism As an Activity Switch for Organometallic Osmium and Ruthenium Anticancer ComplexesJournal of Medicinal Chemistry, 2009
- Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer AgentsChemistry – An Asian Journal, 2008
- Efficient implementation of the gauge-independent atomic orbital method for NMR chemical shift calculationsJournal of the American Chemical Society, 1990
- Caffeine Enhancement of the Effect of Anticancer Agents on Human Sarcoma CellsJapanese Journal of Cancer Research, 1989
- Crystal structure of a compound featuring caffeine bound at C8 to ruthenium (III)Bioinorganic Chemistry, 1975
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965
- On the nuclear magnetic shielding in the hydrogen moleculeMolecular Physics, 1958